Posted by Michael Wonder on 10 May 2021
FDA authorizes Pfizer-BioNTech COVID-19 vaccine for emergency use in adolescents in another important action in fight against pandemic
10 May 2021 - Today, the U.S. FDA expanded the emergency use authorisation for the Pfizer-BioNTech COVID-19 vaccine for the prevention of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 to include adolescents 12 through 15 years of age.
The FDA amended the EUA originally issued on 11 December 2020 for administration in individuals 16 years of age and older.
